|
|
|
Volumn 24, Issue 5, 1997, Pages 561-571
|
|
The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
DACARBAZINE;
DACTINOMYCIN;
DOXORUBICIN;
EPIPODOPHYLLOTOXIN;
ETOPOSIDE;
FLOXURIDINE;
GLYCOPROTEIN P;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
METHOTREXATE;
N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE;
SOMATOMEDIN C;
VINCRISTINE;
VINDESINE;
ADOLESCENT;
ADULT;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CHILD;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
META ANALYSIS;
MULTICENTER STUDY;
OSTEOSARCOMA;
PHASE 2 CLINICAL TRIAL;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
EXTREMITIES;
HUMANS;
OSTEOSARCOMA;
SURVIVAL ANALYSIS;
|
|
EID: 0030867738
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (63)
|
|
References (65)
|
